我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

左心耳封堵联合房颤导管射频消融的进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第1期
页码:
12-015
栏目:
房颤血栓管理-左心耳封堵术
出版日期:
2016-10-05

文章信息/Info

Title:
Progress of left atrial appendage occlusion combined with radiofrequency catheter ablation of atrial fibrillation
作者:
何 斌 综述; 储慧民 审校
（宁波市第一医院心律失常诊疗中心，浙江 宁波 315000）
Author(s):
HE Bin;  CHU Hui-min
(Cardiac Arrhythmia Diagnosis and Treatment Center, Ningbo First Hospital, Ningbo 315000, Zhejiang, China)
关键词:
左心耳封堵术; 房颤导管射频消融; 卒中; 心力衰竭
Keywords:
left atrial appendage occlusion;  radiofrequency catheter ablation;  atrial fibrillation;  stroke;  heart failure
分类号:
R541.7
DOI:
-
文献标识码:
A
摘要:
房颤导管射频消融主要目的是改善患者症状，提高患者生活质量，但不能替代抗凝治疗。而左心耳封堵术可替代抗凝治疗，成为房颤卒中预防的重要治疗手段，但不能改善房颤患者症状。因此左心耳封堵联合射频消融术是不适合口服抗凝药的症状性房颤患者的最佳治疗选择。本文针对联合术式的安全性、有效性以及相互间的影响进行综述。
Abstract:
The main purpose of radiofrequency catheter ablation of atrial fibrillation (AF) is to alleviate the patients’ symptoms and improve their quality of life. However, it is not a substitute for anticoagulation therapy. Left atrial appendage (LAA) occlusion has become an important treatment for the prevention of stroke caused by AF and can substitute for anticoagulation therapy but cannot alleviate the symptoms of patients with AF. Thus, the LAA occlusion combined with radiofrequency ablation should be the best choice for treatment of patients with AF and who are not suitable for oral anti-coagulation. The safety, effectiveness and mutual influence of the hybrid procedure were reviewed in this paper.

参考文献/References

[1]European Heart Rhythm Association1,European Association for Cardio-Thoracic Surgery,ESC Committee for Practice Guidelines,et al.Guidelines for the management of atrialfibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Europace,2010,12(10):1360-1420.
[2]Go AS,Hylek EM,Phillips KA,et al.Prevalence of diagnosed atrial fibrillation in adults:national implications forrhythm management and stroke prevention:the AnTicoagulation and RiskFactors in Atrial Fibrillation(ATRIA)Study[J].JAMA,2001,285(18):2370-2375.
[3]Stewart S,Hart CL,Hole DJ,et al.Population prevalence,incidence,and predictors of atrial fibrillation in the Renfrew/Paisley study[J].Heart,2001,86(5):516-521.
[4]Eikelboom JW,Wallentin L,Connolly SJ,et al.Risk of bleeding with 2 doses of dabigatrancompared with warfarin in older and younger patients with atrial fibrillation:an analysis of the randomized evaluation of long-term anticoagulant therapy(RE-LY) trial[J].Circulation,2011,123(21):2363-2372.
[5]Blackshear JL,Odell JA.Appendage obliteration to reduce stroke in cardiacsurgical patients with atrial fibrillation[J].Ann Thorac Surg,1996,61(2):755-759.
[6]Goldman ME,Pearce LA,Hart RG,et al.Pathophysiologic correlates of thromboembolism in nonvalvularatrial fibrillation:I.Reduced flow velocity in the left atrial appendage(The Stroke Prevention in Atrial Fibrillation[SPAF-III]study)[J].J Am Soc Echocardiogr,1999,12(12):1080-1087.
[7]周 勇,蒋逸风.经皮穿刺左心耳闭合装置的研制及临床应用[J].介入放射学杂志,2013,22(8):698-700.
[8]Oral H,Pappone C,Chugh A,et al.Circumferential pulmonary-vein ablation for chronic atrial fibrillation[J].N Engl J Med,2006,354(9):934-941.
[9]Pappone C,Augello G,Sala S,et al.A randomized trial of circumferential pulmonaryvein ablation versus antiarrhythmic drug therapy in paroxysmal atria lfibrillation:the APAF Study[J].J Am Coll Cardiol,2006,48(11):2340-2347.
[10]Stabile G,Bertaglia E,Senatore G,et al.Catheter ablation treatment in patients with drug-refractory atrial fibrillation:a prospective, multi-centre, randomized,controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study)[J].Eur Heart J,2006,27(2):216-221.
[11]Weerasooriya R,Khairy P,Litalien J,et al.Catheter ablation for atrial fibrillation:are results maintained at 5 years of follow-up?[J].J Am Coll Cardiol,2011,57(2):160-166.
[12]Phillips KP,Walker DT,Humphries JA.Combined catheter ablation for atrial fibrillation and Watchman? left atrial appendage occlusion procedures: Five-year experience[J].Journal of Arrhythmia,2016,32(2):119-126.
[13]Heeger CH,Rillig A,Lin T,et al.Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices[J].Heart Rhythm,2015,12(7):1524-1531.
[14]Romanov A,Pokushalov E,Artemenko S,et al.Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial[J].J Interv Card Electrophysiol,2015,44(1):9-16.
[15]Badhwar N,Lakkireddy D,Kawamura M,et al.Sequential Percutaneous LAA Ligation and Pulmonary Vein Isolation in Patients with Persistent AF:Initial Results of a Feasibility Study[J].J Cardiovasc Electrophysiol,2015,26(6):608-614.

备注/Memo

备注/Memo:
收稿日期：2016-05-31.
通讯作者：储慧民，副主任医师，主要从事心律失常相关研究 Email：markchu@126.com
作者简介：何斌，副主任医师 Email：socrates_he@126.com
更新日期/Last Update: 2016-10-09